insights_auto
Why is TMCI down 3,90%?
Dive Deeperchevron_right
TMCI:NASDAQ
Treace Medical Concepts, Inc
4,44 USD
arrow_downward
-3,90%(-0,18) 1D
4,44 USD
0,00% (0,00)
bedtimeAfter hours
Closed: 30-сен., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
4,62 USD
High
4,62 USD
Low
4,43 USD
Mkt. cap
288,75 млн
Avg. vol.
251,51 миң
Volume
0,00
52-wk high
7,08 USD
52-wk low
1,17 USD
EPS
-0,93 USD
Beta
1,41
Shares outstanding
65,04 млн
No. of employees
450
Open
4,62 USD
High
4,62 USD
Low
4,43 USD
Mkt. cap
288,75 млн
Avg. vol.
251,51 миң
Volume
0,00
52-wk high
7,08 USD
52-wk low
1,17 USD
EPS
-0,93 USD
Beta
1,41
Shares outstanding
65,04 млн
No. of employees
450
News stories
From web sources and news partners
Yahoo Finance
·
1 саат мурун
S&P 500 alarm bells are starting to go off
Moomoo
·
56 мүнөт мурун
Xtrackers S&P500 UCITS ETF subscription
Stock Titan
·
5 мүнөт мурун
Nextdoor expects its stock to start trading on Nasdaq Oct. 14, keeping the same NXDR symbol.
Seeking Alpha
·
31 мүнөт мурун
My Current View Of The SP 500 Index: October 2026 Edition (SPY)
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc